×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GPCR – structure therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GPCR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/17
07:48 am
gpcr
Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target [Seeking Alpha]
Low
Report
Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target [Seeking Alpha]
3/16
02:12 pm
gpcr
Structure Therapeutics (GPCR) had its "outperform" rating reaffirmed by William Blair.
Low
Report
Structure Therapeutics (GPCR) had its "outperform" rating reaffirmed by William Blair.
3/16
12:35 pm
gpcr
Structure Therapeutics Inc. (GPCR) Discusses Positive Topline Results from ACCESS II and Related Studies of Aleniglipron Oral GLP-1 Transcript [Seeking Alpha]
Medium
Report
Structure Therapeutics Inc. (GPCR) Discusses Positive Topline Results from ACCESS II and Related Studies of Aleniglipron Oral GLP-1 Transcript [Seeking Alpha]
3/16
12:23 pm
gpcr
Structure Therapeutics (GPCR) had its price target lowered by HC Wainwright from $114.00 to $100.00. They now have a "buy" rating on the stock.
Low
Report
Structure Therapeutics (GPCR) had its price target lowered by HC Wainwright from $114.00 to $100.00. They now have a "buy" rating on the stock.
3/16
12:08 pm
gpcr
Structure Therapeutics (GPCR) had its "outperform" rating reaffirmed by Leerink Partners.
Low
Report
Structure Therapeutics (GPCR) had its "outperform" rating reaffirmed by Leerink Partners.
3/16
07:08 am
gpcr
Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron [Yahoo! Finance]
Medium
Report
Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron [Yahoo! Finance]
3/16
07:00 am
gpcr
Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
Medium
Report
Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
3/2
08:56 am
gpcr
Structure Therapeutics (GPCR) had its price target raised by HC Wainwright from $90.00 to $114.00. They now have a "buy" rating on the stock.
Low
Report
Structure Therapeutics (GPCR) had its price target raised by HC Wainwright from $90.00 to $114.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/16
08:01 am
gpcr
Form 8-K Structure Therapeutics For: Mar 16
Medium
Report
Form 8-K Structure Therapeutics For: Mar 16
3/5
06:21 pm
gpcr
Form 4 Structure Therapeutics For: Mar 03 Filed by: Coll Crespo Blas
Low
Report
Form 4 Structure Therapeutics For: Mar 03 Filed by: Coll Crespo Blas
3/5
06:21 pm
gpcr
Form 4 Structure Therapeutics For: Mar 03 Filed by: Lin Xichen
Low
Report
Form 4 Structure Therapeutics For: Mar 03 Filed by: Lin Xichen
3/5
06:21 pm
gpcr
Form 4 Structure Therapeutics For: Mar 03 Filed by: Hall Ashley
Low
Report
Form 4 Structure Therapeutics For: Mar 03 Filed by: Hall Ashley
3/5
06:21 pm
gpcr
Form 4 Structure Therapeutics For: Mar 03 Filed by: Ma Yingli
Low
Report
Form 4 Structure Therapeutics For: Mar 03 Filed by: Ma Yingli
3/5
06:21 pm
gpcr
Form 4 Structure Therapeutics For: Mar 03 Filed by: Yoon Jun
Low
Report
Form 4 Structure Therapeutics For: Mar 03 Filed by: Yoon Jun
3/5
06:21 pm
gpcr
Form 4 Structure Therapeutics For: Mar 03 Filed by: Stevens Raymond C
Low
Report
Form 4 Structure Therapeutics For: Mar 03 Filed by: Stevens Raymond C
2/26
05:23 pm
gpcr
Form S-8 Structure Therapeutics
Medium
Report
Form S-8 Structure Therapeutics
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: